Skip to Content

3137 WPI (Nizatidine 150 mg)

Pill with imprint 3137 WPI is White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 3137 WPI

Nizatidine

Imprint:
3137 WPI
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide colloidal
corn starch
croscarmellose sodium
magnesium stearate
pregelatinized corn starch
ammonia
ferric oxide black
gelatin
potassium hydroxide
propylene glycol
shellac
silicon dioxide
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide